The applicants filed an urgent chamber application seeking to suspend the respondent's decision of 12 July 2018 to cancel the first applicant's premises licence and disqualify the second applicant from dealing with medicines or being a Director of any pharmaceutical business for 24 months. The applicants had noted an appeal to the Administrative Court under case No. ACC 74/18. The applicants sought interim relief pending determination of that appeal. The respondent raised four points in limine, primarily challenging: (1) non-compliance with Order 32, Rule 241(1) requiring use of Form 29 as modified for urgent chamber applications; (2) lack of urgency given the pending Administrative Court appeal; (3) that under Section 61(4) of the Medicines and Allied Substances Control Act, the direction had immediate effect notwithstanding the appeal; and (4) that the applicants' proper remedy lay in the Administrative Court. The applicants acknowledged their form was not strictly compliant but argued the court could condone non-compliance under Rule 4C, and that they had ceased operating and surrendered the licence to their legal practitioners.